FisclearFisclear

Financial Comparison

Cipla Limited vs Torrent Pharmaceuticals Limited

Click a ticker to view the full analysis.

CIPLA.NS vs

In short

Torrent Pharmaceuticals Limited is the more profitable of the two, keeping 15.7% of revenue as net profit against 14.0% for Cipla Limited. Torrent Pharmaceuticals Limited trades at the higher trailing P/E (72.5× vs 31.9× for Cipla Limited), so investors pay more for each dollar of its earnings. Fisclear flags 0 medium- or high-severity risks for Cipla Limited and 1 for Torrent Pharmaceuticals Limited.

Based on filings for periods ending 31 Mar 2026 (CIPLA.NS) and 31 Mar 2026 (TORNTPHARM.NS) · Updated

FisclearScore Comparison

CIPLA.NS51Fair
TORNTPHARM.NS66Strong
Quality+15
89
74
Efficiency+13
47
60
Value+26
26
52
Cashflow+51
25
76
Regime
55
55
Peers+18
58
76

FisclearScore is a quantitative model. CIPLA.NS shown solid · TORNTPHARM.NS shown dashed. Not financial advice.

MetricCIPLA.NSTORNTPHARM.NS
Price₹1,310.50₹4,632.70
Market Cap₹1.06T₹1.76T
P/E (TTM)31.9x72.5x
P/B3.1x18.7x
Beta0.090.14
Div Yield0.99%0.81%
Revenue (TTM)₹277.1B₹137.5B
Net Income₹38.8B₹21.6B
Gross Margin62.3%74.4%
Risk Flags—1 flag
Full CIPLA.NS Report →Full TORNTPHARM.NS Report →

Related comparisons

CIPLA.NS vs Sun PharmaceuticalSun Pharmaceutical vs TORNTPHARM.NSCIPLA.NS vs Dr. Reddy's LaboratoriesDr. Reddy's Laboratories vs TORNTPHARM.NSCIPLA.NS vs DIVISLAB.NSAPOLLOHOSP.NS vs CIPLA.NS

Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.